[Hypertension in acromegaly].
Kumagai
Hiroo
H
Department of Internal Medicine, Keio University School of Medicine.
Onami
Toshiko
T
Iigaya
Kamon
K
Hayashi
Koichi
K
Saruta
Takao
T
D000172:Acromegaly / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D001794:Blood Pressure; D001971:Bromocriptine / Q000627:therapeutic use; D002940:Circadian Rhythm; D019382:Human Growth Hormone / Q000502:physiology; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology*; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D015282:Octreotide / Q000627:therapeutic use; D010953:Plasma Volume; D012964:Sodium / Q000378:metabolism; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014655:Vascular Resistance
D019382:Human Growth Hormone; D001971:Bromocriptine; D007334:Insulin-Like Growth Factor I; D012964:Sodium; D015282:Octreotide